One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1016/j.annonc.2023.09.278
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Nov 1, 2023 |
Affiliation: University of Virginia, National Cancer Center Hospital East, Hackensack University Medical Center, University of Florida, Roswell Park Cancer Institute, University of Arizona, Juntendo University Hospital, University of Miyazaki Hospital, Osaka University Hospital, Cornell University, Memorial Sloan Kettering Cancer Center
MO50-3 Preliminary data from the phase I/II study of TP-3654, an oral PIM-1 kinase inhibitor, in patients with myelofibrosis
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
